Ken Fisher acquired 15 Million GSK Plc - ADR shares worth $614 Million. That's 0.31% of their equity portfolio (86th largest holding). The first GSK Plc - ADR trade was made in Q1 2013. Since then Ken Fisher bought shares 33 more times and sold shares on ten occasions. The investor's estimated purchase price is $636 Million, resulting in a loss of 3.5%.
Emulating the moves of hedge fund stock pickers, and some of the most successful hedge funds can produce sizable profits for retail investors. In fact, here ...
InvestorPlace, 8 months agoMajor players in the pharmacogenomics market are Abbott Laboratories, AstraZeneca plc, Becton Dickinson and Company, Bayer AG, F Hoffmann-La Roche AG, Illumi...
GlobeNewswire, over 1 year ago